Helen Murray Free Endowed Lectures

Wishart Hall, Lean Lecture

Shining light on hidden players in disease

Public Lecture

Amanda Hargrove, PhD

Duke University, Durham, N.C.

Amanda E. Hargrove is a Professor of Chemistry at Duke University. Prof. Hargrove earned her Ph.D. in Organic Chemistry from the University of Texas at Austin followed by an NIH postdoctoral fellowship at Caltech.  Prof. Hargrove’s laboratory at Duke focuses on developing small molecule probes to investigate the structure and function of RNA molecules relevant to human disease. The lab works to understand the fundamental drivers of selective small molecule:RNA recognition and to use this knowledge to functionally modulate viral and oncogenic RNA structures. Congruent with the interdisciplinary nature of this program, Prof. Hargrove holds a secondary appointment in the Biochemistry Department and membership in the Duke Cancer Institute, the Pharmaceutical Sciences Training Program, and the Center for Biological and Tissue Engineering. Recent honors include the Sloan Research Fellowship, American Chemical Society Women Chemists Committee Rising Star Award, Cram Lehn Pedersen Prize in Supramolecular Chemistry, ChemComm Emerging Investigator Lectureship, RSC Medicinal Chemistry Emerging Investigator Lectureship, and the NSF CAREER Award. Prof. Hargrove serves as Editor-in-Chief of Medicinal Research Reviews and is a member of the ChemComm, Current Protocols, and Supramolecular Chemistry editorial advisory boards. In July 2024, the Hargrove lab will move to the University of Toronto Center for Medicinal Chemistry in Mississauga.

Reception will follow immediately after the evening lecture sponsored by the Wooster Section of the American Chemical Society

• Professor of Chemistry, Duke University
• Associate Professor of Biochemistry, Duke University Medical School
• Board of Advisors, Trinity University Chemistry Department (2023-Present)
• Scientific Advisory Board Member, Arrakis Therapeutics (2021-Present)
• Editor-in-Chief: Medicinal Research Reviews (2019-Present)
• Editorial Board Member: Current Protocols; Chemical Communications; Supramolecular Chemistry